<DOC>
	<DOCNO>NCT01477619</DOCNO>
	<brief_summary>The purpose research study understand whether difference amount tasimelteon blood smoker versus non-smokers . Additionally , study provide assessment effect , , age body size safety tolerability profile pharmacokinetics tasimelteon .</brief_summary>
	<brief_title>Effects Smoking , Age Body Size Pharmacokinetics , Safety Tolerability Tasimelteon Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Groups 1 2 : 1 . Men woman 18 55 year , inclusive ; 2 . Smokers test positive cotinine screen baseline smoke least 10 cigarette per day , least 6 month prior screen ( Group 1 ) OR Nonsmokers [ abstinence smoking least 6 month screen visit test negative cotinine screen baseline ( Group 2 ) ] match Group 1 gender , age ( ±10 year ) , BMI category [ underweight/normal ( ≤ 24.99 ) , overweight ( 25.0029.99 ) , obese ( ≥ 30.00 ) ] ; 3 . Males , nonfecund female ( i.e. , surgically sterilize , procedure do 6 month screen subject postmenopausal , without menses 6 month screen ) , females childbearing potential use acceptable method birth control period 35 day first dose female must negative pregnancy test screen baseline visit ; Note 1 : Acceptable method birth control include one following : abstinence , vasectomize sexual partner , hormonal method ( i.e . pill , hormonal IUD , DepoProvera , implant , patch , intravaginal device [ NuvaRing ] ) , intrauterine device ( IUD [ copper band coil ] ) , diaphragm , cervical cap , condom spermicidal jelly foam . 4 . Vital sign ( 3 minute rest semisupine position ) within range show : Body temperature 35.037.5 °C ; Systolic blood pressure 90150 mmHg ; Diastolic blood pressure 5095 mmHg ; Pulse rate 50100 bpm . Group 3 : 1 . Men woman 65 year age old ; 2 . Nonsmokers ( abstinence smoking least 6 month start study test negative cotinine screen baseline ) ; 3 . Vital sign ( 3 minute rest semisupine position ) within range show : Systolic blood pressure 90160 mmHg ; Diastolic blood pressure 5099 mmHg ; Pulse rate 50100 bpm . Groups 13 : 1 . Ability acceptance provide write informed consent ; 2 . Willing able comply study requirement restriction ; 3 . Subjects must good health determine past medical history , physical examination , electrocardiogram , clinical laboratory test urinalysis ; 1 . History recent ( within six month ) drug alcohol abuse define DSM IV , Diagnostic Criteria Drug Alcohol Abuse evidence abuse indicate laboratory assay conduct Screening Visit Baseline ; 2 . Any major surgery within three month Baseline minor surgery within one month ; 3 . History current evidence cardiovascular , hepatic , hematopoietic , renal , gastrointestinal metabolic dysfunction judge Investigator clinically significant ; 4 . Any condition require regular use medication except listed Section 8.2 ; 5 . Use melatonin preparation chronically within 2 month prior Day 1 drug know cause major organ system toxicity ( e.g. , chloramphenicol tamoxifen ) within 60 day prior Day 1 . 6 . Exposure investigational drug , include placebo , within 30 day 5 halflives ( whichever longer ) baseline ; 7 . Donation loss 400 mL blood within two month prior Baseline Visit ; 8 . Significant illness within two week prior Baseline ; 9 . A known hypersensitivity tasimelteon drug similar tasimelteon include melatonin ; 10 . Pregnant lactating female ; 11 . History liver disease and/or positive one follow serological result : A positive hepatitis C antibody test ( antiHCV ) A positive hepatitis B surface antigen ( HBsAg ) 12 . A positive HIV test result 13 . Any surgical medical condition might significantly alter absorption , distribution excretion drug . The Investigator guide evidence following : Clinically significant gastritis , ulcer , gastrointestinal rectal bleeding within 5 year screen visit ; History inflammatory bowel syndrome , major gastrointestinal tract surgery gastrectomy , gastroenterostomy , bowel resection ; Pancreatic injury pancreatitis within 5 year screen visit ; Clinically significant urinary obstruction difficulty void within 3 year screen visit ; 14 . Exposure ( within 2 week Baseline Visit ) overthecounter medication include dietary supplement and/or herbal remedy , except list Section 8.2 ; 15 . Use food beverage contain grapefruit grapefruit juice , apple orange juice , vegetables mustard green family ( e.g . kale , broccoli , watercress , collard green , kohlrabi , Brussels sprout , mustard green ) charbroiled meat least 2 week Baseline Visit end study ; 16 . Inability venipunctured and/or tolerate venous access ; 17 . Subjects unable read speak English ; 18 . Participation previous BMS214778/VEC162 trial ; 19 . Any sound medical reason determine clinical Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Pharmacokinetics</keyword>
</DOC>